A new Redeye interview with Michael Brobjer, AroCell CEO, commenting interim report for the second quarter of 2020. See the interview on Redeye's website.
Redeye-intervju med Michael Brobjer
läs mer
Nyheter
Senaste nytt.
Two new publications on UBC Rapid
A publication presented in Entropy shows the value of UBC® Rapid Read the press release here and here
Affärsutvecklingschef Asien
IDL Biotech has appointed Subyung Park as Business Development Manager Asia with a focus on the product TUBEX® TF. Read the press release here
Ny forskningsrapport om AroCells tidigare analys från Redeye
Redeye has today released a new research note on the previous analysis of Arocell. The full report can be found on their website. Link to Redeye's new research note.
AroCell Strategidag 2020
Time: 10.00 - 12.00 CEST, June 15th 2020 On June 15, Arocell AB provides a live broadcast business update with subsequent question time led by Redeye’s analyst Oscar Bergman. CEO Michael Brobjer, together with parts of the management team, will among other things...
Ny artikel i DI
Länk
AACR 2020: Nya data om AroCell TK 210 ELISA nu online
Two abstracts accepted for the American Association of Cancer Research 2020 (AACR 2020) has now been published online. The first study entitled “Evaluation of TK1 protein changes using the AroCell TK 210 ELISA in an acute myeloid leukemia (AML) xenograft model during...
IDL Biotech signs new distribution agreement with Beckman Coulter, which gives the distributor global sales rights for the company’s tumor markers on the ELISA manual platform.
Beckman Coulter has been one of IDL Biotech's most successful tumor markers distributors, and has sold the products in the Czech Republic and Slovakia for many years. With Beckman Coulter now taking over the global distribution rights for the company's tumor markers,...
Registration of TUBEX TF approved in Indonesia
The registration of TUBEX TF has been approved in Indonesia. Read the press release here
IDL Biotech signs distributor agreement in Zimbabwe
IDL Biotech continues to expand in Africa. IDL Biotech has signed a distributor agreement with PHM Diagnostic Lab Ltd in Zimbabwe. Read the press release here
